SELLAS Life Sciences Group short interest was 32.33% of the float on June 30th, according to new data we received from Benzinga. Short interest totaled 63,307,462 shares, which was a decrease of -0.08% from June 15th.
It is estimated that it would take 4.75 days for short sellers to buy back their shares, with current trading volumes.
SELLAS Life Sciences Group Hedge Fund Activity
We have seen 107 institutional investors add shares of SELLAS Life Sciences Group stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STATE STREET CORP added 6,208,185 shares (+283.7%) to their portfolio in Q1 2026, for an estimated $26,260,622
- BLACKROCK, INC. added 4,657,356 shares (+61.8%) to their portfolio in Q1 2026, for an estimated $19,700,615
- JONES FINANCIAL COMPANIES LLLP added 1,245,834 shares (+290.2%) to their portfolio in Q1 2026, for an estimated $5,269,877
- MILLENNIUM MANAGEMENT LLC removed 1,228,325 shares (-88.5%) from their portfolio in Q1 2026, for an estimated $5,195,814
- GEODE CAPITAL MANAGEMENT, LLC added 835,269 shares (+27.1%) to their portfolio in Q1 2026, for an estimated $3,533,187
- UBS GROUP AG added 696,692 shares (+1429.8%) to their portfolio in Q1 2026, for an estimated $2,947,007
- MARSHALL WACE, LLP added 696,494 shares (+52.0%) to their portfolio in Q1 2026, for an estimated $2,946,169
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
